Menu

Latest Pharma Insights



Novartis Looks To Maintain A Lead In Radiopharmaceuticals With Mariana Takeout
The acquisition of Mariana will complement Novartis’s lutetium-based radioligand therapies with candidates using actinium. Lilly, Bristol and AstraZeneca all have...
Scrip - May 2, 2024
Attorney: Proposed Data Privacy Law Would Ultimately Reduce Regulatory Burden
Data privacy lawyer says the comprehensive, bipartisan law is “catching a lot of people’s ears.”
Medtech Insight - May 2, 2024
Bausch + Lomb’s Prescription For Consumer Health Sales Growth Includes ‘Benefit’ From Rx Drugs
Blink NutriTears supplement containing lutein/zeaxanthin, curcumin and vitamin D3 coming in 2024 is example of a cross-segment sales benefit B+L...
HBW Insight - May 2, 2024
Dupixent COPD Approval Could Be Delayed, Regeneron Cautions
The US Food and Drug Administration has requested additional efficacy information on the supplemental filing in the potentially large new...
Scrip - May 2, 2024
ICER Debuts Clinical Trial Diversity Assessment Framework
The new tool provides a way of quantifying the degree of diversity by race/ethnicity, sex and age in clinical trials...
Pink Sheet - May 2, 2024
Senseonics Wins Marketing Authorization For Novel Insulin Delivery System
The US FDA has cleared a glucose monitoring system from Senseonics. The authorization of the implantable insulin delivery system creates...
Medtech Insight - May 2, 2024
Liquid Biopsy Company Karius Raised $100M To Expand Its Test For Detecting Over 1,000 Pathogens
Karius announced on 2 May that it has raised $100m in a series C round of financing co-led by Khosla...
Medtech Insight - May 2, 2024
Global Medtech Guidance Tracker: April 2024
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Thirty-five documents have been posted on...
Medtech Insight - May 2, 2024
US FDA Wants Advice About Advisory Committees: Try Having Some?
The FDA’s drug center has all but stopped holding meetings at this point, which begs the question: why do they...
Pink Sheet - May 2, 2024
Competition Forces Price Cuts, But Novo Nordisk Is Unstoppable
Novo raises its top- and bottom-line guidance as it prioritizes volume over price.    
Scrip - May 2, 2024
Metagenomi Looks For Upside To Moderna’s Exit
Moderna has cut short its alliance with Metagenomi, giving it more work to do in persuading skeptical investors about its...
Scrip - May 2, 2024
Executives On The Move: Senior Moves At Innovent Biologics, Actym Therapeutics And Enanta Pharmaceuticals
Recent moves in the industry also include C-suite shuffles at Faron Pharmaceuticals and new chief financial officers at Orion, BioVaxys Technology...
Scrip - May 2, 2024
Shionogi: Other Countries Must Follow UK’s Lead On Antimicrobial Incentives
Shionogi’s UK general manager praised NHS England’s novel subscription model for antibiotics, but warned the country would be “wasting money”...
Pink Sheet - May 2, 2024
Haleon Capitalizes On Global Rebound Of Dietary Supplement Sales
Haleon gets its dietary supplements growth engine firing in Q1 with VMS sales up almost 10% as the firm's three...
HBW Insight - May 2, 2024
Industry Calls For Caution Over EMA Supply Chain Recommendations
The European Medicines Agency has published guidance on how to strengthen the supply chain for products included on the EU’s...
Pink Sheet - May 2, 2024
Industry Slates Decision To Exempt Parallel Importers From New Danish Stockpile Rules
The bill on new rules on companies holding minimum stock levels for “critical medicines” has been amended but is still...
Pink Sheet - May 2, 2024
Who’s Hired? Teva Brings New Legal Head Onboard
Generics Bulletin reports on some of the most noteworthy and important appointments affecting the global generics and biosimilar industries.
Generics Bulletin - May 2, 2024
Chanelle McCoy, Cannaray First To Pass UK FSA’s CBD Safety Assessment
CBD products produced by Chanelle McCoy Health and Cannaray have been given the green light by the Food Standards Agency's Advisory...
HBW Insight - May 2, 2024
OTC Marketing Awards 2024 Now Open For Entries
Returning for its 29th year, the Oscars of the OTC industry is now inviting entries from UK consumer health players...
HBW Insight - May 2, 2024
Addex Gets Creative To Secure Funding And Its Future
Addex Therapeutics’ Tim Dyer has seen the company through 22 years of ups and downs. He has kept the company...
In Vivo - May 2, 2024
Japan Results Roundup: Weak Yen Provides A Boost But Some Sales Challenges Emerge
The weak yen helped push up both global revenues and costs for major Japanese firms in the fiscal year ended...
Scrip - May 2, 2024

Novartis Looks To Maintain A Lead In Radiopharmaceuticals With Mariana Takeout
The acquisition of Mariana will complement Novartis’s lutetium-based radioligand therapies with candidates using actinium. Lilly, Bristol and AstraZeneca all have...
Scrip - May 2, 2024
Dupixent COPD Approval Could Be Delayed, Regeneron Cautions
The US Food and Drug Administration has requested additional efficacy information on the supplemental filing in the potentially large new...
Scrip - May 2, 2024
Competition Forces Price Cuts, But Novo Nordisk Is Unstoppable
Novo raises its top- and bottom-line guidance as it prioritizes volume over price.    
Scrip - May 2, 2024
Metagenomi Looks For Upside To Moderna’s Exit
Moderna has cut short its alliance with Metagenomi, giving it more work to do in persuading skeptical investors about its...
Scrip - May 2, 2024
Executives On The Move: Senior Moves At Innovent Biologics, Actym Therapeutics And Enanta Pharmaceuticals
Recent moves in the industry also include C-suite shuffles at Faron Pharmaceuticals and new chief financial officers at Orion, BioVaxys Technology...
Scrip - May 2, 2024
Japan Results Roundup: Weak Yen Provides A Boost But Some Sales Challenges Emerge
The weak yen helped push up both global revenues and costs for major Japanese firms in the fiscal year ended...
Scrip - May 2, 2024

ICER Debuts Clinical Trial Diversity Assessment Framework
The new tool provides a way of quantifying the degree of diversity by race/ethnicity, sex and age in clinical trials...
Pink Sheet - May 2, 2024
US FDA Wants Advice About Advisory Committees: Try Having Some?
The FDA’s drug center has all but stopped holding meetings at this point, which begs the question: why do they...
Pink Sheet - May 2, 2024
Shionogi: Other Countries Must Follow UK’s Lead On Antimicrobial Incentives
Shionogi’s UK general manager praised NHS England’s novel subscription model for antibiotics, but warned the country would be “wasting money”...
Pink Sheet - May 2, 2024
Industry Calls For Caution Over EMA Supply Chain Recommendations
The European Medicines Agency has published guidance on how to strengthen the supply chain for products included on the EU’s...
Pink Sheet - May 2, 2024
Industry Slates Decision To Exempt Parallel Importers From New Danish Stockpile Rules
The bill on new rules on companies holding minimum stock levels for “critical medicines” has been amended but is still...
Pink Sheet - May 2, 2024

Attorney: Proposed Data Privacy Law Would Ultimately Reduce Regulatory Burden
Data privacy lawyer says the comprehensive, bipartisan law is “catching a lot of people’s ears.”
Medtech Insight - May 2, 2024
Senseonics Wins Marketing Authorization For Novel Insulin Delivery System
The US FDA has cleared a glucose monitoring system from Senseonics. The authorization of the implantable insulin delivery system creates...
Medtech Insight - May 2, 2024
Liquid Biopsy Company Karius Raised $100M To Expand Its Test For Detecting Over 1,000 Pathogens
Karius announced on 2 May that it has raised $100m in a series C round of financing co-led by Khosla...
Medtech Insight - May 2, 2024
Global Medtech Guidance Tracker: April 2024
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Thirty-five documents have been posted on...
Medtech Insight - May 2, 2024

Bausch + Lomb’s Prescription For Consumer Health Sales Growth Includes ‘Benefit’ From Rx Drugs
Blink NutriTears supplement containing lutein/zeaxanthin, curcumin and vitamin D3 coming in 2024 is example of a cross-segment sales benefit B+L...
HBW Insight - May 2, 2024
Haleon Capitalizes On Global Rebound Of Dietary Supplement Sales
Haleon gets its dietary supplements growth engine firing in Q1 with VMS sales up almost 10% as the firm's three...
HBW Insight - May 2, 2024
Chanelle McCoy, Cannaray First To Pass UK FSA’s CBD Safety Assessment
CBD products produced by Chanelle McCoy Health and Cannaray have been given the green light by the Food Standards Agency's Advisory...
HBW Insight - May 2, 2024
OTC Marketing Awards 2024 Now Open For Entries
Returning for its 29th year, the Oscars of the OTC industry is now inviting entries from UK consumer health players...
HBW Insight - May 2, 2024

Who’s Hired? Teva Brings New Legal Head Onboard
Generics Bulletin reports on some of the most noteworthy and important appointments affecting the global generics and biosimilar industries.
Generics Bulletin - May 2, 2024

Addex Gets Creative To Secure Funding And Its Future
Addex Therapeutics’ Tim Dyer has seen the company through 22 years of ups and downs. He has kept the company...
In Vivo - May 2, 2024